Current Advances in γδ T Cell-Based Tumor Immunotherapy.
about
Human γδ T-Cell Control of Mucosal Immunity and Inflammation.Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local.Zoledronate Triggers Vδ2 T Cells to Destroy and Kill Spheroids of Colon Carcinoma: Quantitative Image Analysis of Three-Dimensional Cultures.Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer.Dendritic Cells Are Critical for the Activation and Expansion of Vδ2 T Cells After Allogeneic Hematopoietic Transplantation
P2860
Current Advances in γδ T Cell-Based Tumor Immunotherapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Current Advances in γδ T Cell-Based Tumor Immunotherapy.
@en
Current Advances in γδ T Cell-Based Tumor Immunotherapy.
@nl
type
label
Current Advances in γδ T Cell-Based Tumor Immunotherapy.
@en
Current Advances in γδ T Cell-Based Tumor Immunotherapy.
@nl
prefLabel
Current Advances in γδ T Cell-Based Tumor Immunotherapy.
@en
Current Advances in γδ T Cell-Based Tumor Immunotherapy.
@nl
P2093
P2860
P50
P356
P1476
Current Advances in γδ T Cell-Based Tumor Immunotherapy.
@en
P2093
Eliana Gulotta
Gabriele Pizzolato
Gaspare Gulotta
Serena Meraviglia
P2860
P356
10.3389/FIMMU.2017.01401
P577
2017-10-27T00:00:00Z